• Venetoclax added to fludarabine, cytarabine and gemtuzumab ozogamicin (drug combination) in children with relapsed acute myeloid leukemia

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Czechia Denmark Finland France +8

  • Accelerating improvement with teclistamab plus standard drug combination in newly diagnosed transplant‑eligible multiple myeloma patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany

  • Discontinuation of methotrexate (drug combination) in rheumatoid arthritis patients using TNF inhibitors

    Recruiting

    3 1 1 1
    Investigated Drugs:
    The Netherlands

  • Long‑term immunity after a 6‑month‑old MMR vaccine (live attenuated) in infants: follow‑up of antibody levels 1‑3 years after routine vaccination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark

  • Study of MK-1045 plus rituximab in patients with newly diagnosed follicular lymphoma

    Recruiting

    4 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Greece Italy Poland Spain

  • Semaglutide for weight management in adults with obesity and binge‑eating: a study to identify who benefits

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium

  • A Phase 2a Study of ly4005130 in Adults with Severe Alopecia Areata

    Recruiting

    2 1
    Investigated Diseases:
    The Netherlands Poland

  • Phase Ib/II Study of Bexmarilimab Plus Doxorubicin in Adults with Metastatic Soft Tissue Sarcoma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain

  • Continuation study of JDQ443 in patients with KRAS G12C‑mutated non‑small cell lung cancer receiving JDQ443 as monotherapy or drug combination

    Recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Denmark France Italy Spain

  • Phase IIb Randomized, Double‑Blind Study of GIA632 in Adults with Nonsegmental Vitiligo

    Recruiting

    2 1
    Investigated Diseases:
    France Germany Italy The Netherlands Spain

powered by